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Abstract
Many patients and health care providers lack awareness of both the existence of, and treatments 
for, lingering distress and disability after treatment. A cancer survivorship wellness plan can help 
ensure that any referral needs for psychosocial and other restorative care after cancer treatment are 
identified.
As a consequence of continuing advances in the detection and treatment of cancer at all 
stages of the disease, there are now more than 13 million cancer survivors in the U.S.; 
500,000 of them received health care services in the VHA.1,2 Given this shifting trajectory 
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of survivorship, for many patients, cancer is better understood as a chronic illness. As such, 
ongoing care after cancer treatment has assumed greater significance.
This article describes the bio-psychosocial needs of cancer survivors and discusses the 
development of a VHA Computerized Patient Record System (CPRS) survivorship care plan 
(SCP) that includes a wellness plan to guide patient care. The description of cancer survivors 
relies on the literature as well as on the Veterans Cancer Rehabilitation Study (Vetcares) of 
170 veterans diagnosed with oral and digestive cancers (ie, head and neck, gastric/ 
esophageal, colorectal) who were interviewed at 6, 12, and 18 months after their diagnosis 
(described in detail elsewhere).3
PSYCHOSOCIAL DISTRESS AFTER CANCER
A cancer diagnosis is usually received suddenly and unexpectedly. Cancer continues to be 
the most commonly feared diagnosis; receiving the diagnosis can be traumatic. Treatments 
can be harsh and significantly disrupt daily life. After the physical rigors of treatment 
subside, depression and anxiety may emerge as the impact of diagnosis and treatment are 
processed.
Depression
After cancer treatment, approximately 1 in 4 individuals meets criteria for depression.4,5 
Depression frequently results in significant additional disability in survivors. The risk for 
depressive symptoms is highest in the first year following treatment. Studies conflict about 
whether the risk for depression continues to be greater in long-term cancer survivors or is 
equal to that in the general population, but in the Vetcares sample, 18% continued to exceed 
a standard rating scale cutoff for major depression at 18 months postdiagnosis (Table 1).6–8
Anxiety
Many individuals report symptoms of cancer-related posttraumatic stress disorder (PTSD) in 
the first year following cancer treatment.9 Approximately 1 in 10 meets the criteria for 
PTSD, although longitudinal studies are lacking.10 In the Vetcares sample, 80% experienced 
at least 1 symptom of cancer-related PTSD, and 10% exceeded a standard rating scale cutoff 
for PTSD.11 In a veteran population, concurrent combat PTSD may be associated with 
cancer PTSD; 36% of the Vetcares sample said cancer reminded them of combat, and 23% 
said dreams of combat became more frequent during cancer.12 In addition to the intrusive 
symptoms of cancer-related stress, fears of recurrence are common.13 In the Vetcares study, 
veterans reported fear of recurrence, worries about family, health and health care, and 
existential concerns (eg, “Am I making the most of the time I have?”).14
Social Interference
Long-term adverse effects of cancer, when untreated, decrease the capacity for work and 
create social strain.15–17 This veteran sample reported that cancer interfered with marital and 
family relationships (45%), social and recreational activities (43%), work (46%), and 
finances (37%).18 Restrictions on socialization may be especially problematic, given that 
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social support is a critical predictor of coping ability during the process of cancer diagnosis 
and treatment.19,20
FUNCTIONAL DISABILITY AFTER CANCER
Cancer treatment may involve removal of the breast, prostate, bladder, colon, esophagus, or 
other body part and, as a result, may be accompanied by changes in physical function. In 
addition, persistent toxicities of chemotherapy and radiation therapy across organ systems 
may lead to diffuse problems.
Neuropsychiatric Disability (Cognition, Insomnia, Fatigue)
Cognitive problems with speed of processing, short-term memory, spatial abilities, and word 
finding have been noted across cancer types, although the extent of impairment varies, 
depending on treatments.21,22 In the Vetcares population, an astounding 1 in 2 experienced 
impaired cognition (<26 adjusted Montreal Cognitive Assessment [MoCA] score),23 while 
nearly 1 in 3 reported significant insomnia or fatigue via the Patient Reported Outcomes 
Measurement Information System (PROMIS) (Table 2).24
Musculoskeletal Disability (Physical Function, Pain)
Physical impairments in strength, range of motion, and balance may be associated with 
generalized treatments like chemotherapy and with targeted treatments such as major 
surgical resections. Older cancer survivors may have more functional disability than do 
younger survivors; in the Vetcares sample, about 1 in 2 described problems with physical 
function (eg, difficulty doing chores, climbing stairs, walking, shopping).25,26 Pain is 
common during cancer treatment and may continue after treatment is completed; 1 in 3 in 
the Vetcares sample continued to report significant pain 18 months after diagnosis.27,28 
Causes are multifactorial, such as chemotherapy-induced peripheral neuropathy or 
postsurgical syndromes.29
Other Disabilities
In addition to neuropsychiatric and musculoskeletal impairments, a wide range of other 
functional limitations are found, depending on the cancer and its treatment. Sexual 
complaints, which should not be confused with lack of interest, are one of the most 
prevalent, long-term complications of cancer.30 In the Vetcares sample, almost half (43%) 
the veterans stated that their sex lives were worse than they were before cancer, yet 73% 
said that their interest in sex was the same or stronger. In addition, disruption in 
gastroenterological function is common, with both weight loss and weight gain.31 Other 
functional challenges may include difficulties with speech, swallowing, and for patients who 
have them, difficulties with mechanical devices (eg, a feeding tube) and stoma care.17,32 
Bladder and bowel functions may be affected as well.33–35
HEALTH CARE AFTER CANCER
Oncology research has resulted in remarkable strides in the development of treatments that 
extend life. After cancer treatment, oncologists focus appropriately on ongoing surveillance 
for recurrence. However, many patients, and possibly some health care professionals, lack 
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awareness of both the existence of, and treatments for, lingering distress and disability after 
treatment.36,37
For example, one Vetcares patient said he wished his physicians had prepared him for his 
symptoms after treatment. “[I wish the doctors would say]…‘It may take a while, but you 
may recover…’ I was never talked to about how life would be afterwards—not just physical, 
but your life.” He expressed a wish for “…a phone call every few weeks to check in…I sort 
of navigated it myself.” The lack of awareness and preparation for the chronic care needs of 
cancer survivors may be a relic of the discontinuity between specialty oncology services and 
primary care delivery before and after acute cancer care.
With its integration of inpatient and outpatient services across primary and specialty care, 
VHA is a leading-edge provider of comprehensive cancer survivorship care. To ensure that 
VHA is meeting the chronic care needs of the veterans who are cancer survivors, assessment 
and treatment planning services, in addition to including traditional screening and 
surveillance programs, should also be aligned with survivors’ biopsychosocial needs.
The Survivorship Care Plan
The Institute of Medicine (IOM), recognizing the need for treatment of both psychosocial 
distress and functional disability after cancer treatment, released the report, From Cancer 
Patient to Cancer Survivor: Lost in Transition,31 in 2005, followed in 2008 by Cancer Care 
for the Whole Patient: Meeting Psychosocial Health Needs.38 An SCP has been proposed to 
document patient and provider awareness of the need for postcancer treatment rehabilitation, 
broadly conceived, and to direct patients to appropriate referrals.29
Ideally, an SCP provides (1) a summary of cancer treatment; (2) a plan for surveillance and 
preventive care; and (3) recommendations for rehabilitative care (although the latter are 
often missing). The SCP has been widely embraced by patient groups and by the American 
Society of Clinical Oncologists. The Commission on Cancer (CoC) of the American College 
of Surgeons proposed a new accreditation standard, to begin in 2015, which will require “a 
process to disseminate a comprehensive care summary and follow-up plan to patients with 
cancer who are completing cancer treatment.”39 While the SCP is a promising tool, it may 
facilitate survivorship care best when it is patient centered—that is, when it is used to elicit 
and personalize the individual’s stated needs and goals for health care.40–42
There are obstacles to implementing an SCP. The IOM recommends that the patient’s 
“managing physician” be the plan’s author, but that specialty cannot be uniformly 
established. Specific cancer diagnoses and treatment needs dictate which physicians are 
involved in comprehensive cancer and survivorship care, and increasingly, these roles are 
complex and poorly coordinated.43 Thus, the provider responsible for creating the treatment 
summary or interviewing the patient will vary, and oversight of the implementation process 
will necessarily be fragmented. In addition, patients may deliberately avoid care; in the 
Vetcares sample, nearly half admitted to staying away from the medical center after 
treatment ceased because of being “tired of it all.” Others shunned post cancer treatment 
follow-up due to fears that tests might reveal bad news.
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A VHA Template
A working group within the VHA special interest group on cancer survivorship developed a 
CPRS (Computerized Patient Record System) template for an SCP that is based on the IOM 
recommendations. The group translated these recommendations into the relevant clinical 
data elements using 3 components: (1) a treatment summary; (2) a surveillance plan; and (3) 
a wellness plan (Figure). For those working within the VA system, the template is available 
on the VA intranet for download into the local CPRS template package. Local sites can then 
adapt the template as desired.
The Wellness Plan Component
A key part of this SCP that distinguishes it from others is the wellness plan. Importantly, this 
component asks the patient to report, to his primary care physician or other provider, 
specific concerns that may warrant referrals for rehabilitative care. In this way, the VHA 
SCP elicits patient participation and perspective to a greater extent than those plans that 
focus more narrowly on summarizing treatment. The items on the wellness plan were chosen 
based on the frequency with which they were identified among the veterans in the study 
sample as well as on a consensus of the VHA working group’s members.
Consumer feedback, as provided by 4 veterans who piloted the SCP, suggested that the plan 
should be completed approximately 3 months after cancer treatment. Because of variables in 
cancer treatment and in the organizational structure of VA facilities nationwide, flexibility in 
using and adapting these tools is inevitable and desirable. Since the majority of survivorship 
research focuses on women who are breast cancer survivors, while the data presented here 
are based on oral-digestive cancer survivors, additional work is needed to cross-validate the 
wellness plan content across cancer types as well as to determine effective methods for 
implementation that address both system and patient barriers to care.
CONCLUSION
Awareness of the need for cancer survivorship care is growing nationwide and within the 
VHA, and will become a required standard for CoC accreditation in 2015. With the VA’s 
leadership in both electronic medical records and integrated care, we are well poised to set 
an example of meaningful, patient-centered survivorship care.
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Fast Facts…
• There are now more than 13 million cancer survivors in the U.S.; 500,000 in the 
VHA1,2
• Psychosocial distress and functional disability are common after cancer 
treatment. These problems often go untreated, increasing risk for ongoing 
disability
• The survivorship care plan (SCP) is a mechanism to improve transition care by 
providing information, education, and referral, but traditional approaches have 
lacked the patient’s perspective
• A wellness plan template has been developed to augment survivorship care 
planning in the VHA
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Figure. VHA Wellness Plan Template
Source: https://vaww.visn11.portal.va.gov/sites/VERC/va-case/collabs/survivor_toolkit/
SitePages/Home.aspx (Note: this is an internal VA website accessible to VA personnel only.
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